Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardian Pharmacy Services (GRDN) Capital Expenditures (2024 - 2025)

Historic Capital Expenditures for Guardian Pharmacy Services (GRDN) over the last 2 years, with Q3 2025 value amounting to $4.0 million.

  • Guardian Pharmacy Services' Capital Expenditures rose 8046.91% to $4.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $8.5 million, marking a year-over-year change of. This contributed to the annual value of $14.7 million for FY2024, which is 139340.1% up from last year.
  • According to the latest figures from Q3 2025, Guardian Pharmacy Services' Capital Expenditures is $4.0 million, which was up 8046.91% from $2.2 million recorded in Q4 2024.
  • Over the past 5 years, Guardian Pharmacy Services' Capital Expenditures peaked at $4.0 million during Q3 2025, and registered a low of $2.2 million during Q3 2024.